Quality-Assured Medicines: A Key Factor for TB Elimination
*Recommended Audience: Mid-Level Professionals
Sustainable supply of quality-assured medicines is crucial in the global fight to end TB. The pool of internationally available quality-assured TB medicines has increased, which has helped address supply vulnerabilities and stabilize prices. However, many countries are graduating from procuring medicines through quality-assured sources such as GDF and are now beginning to procure medicines domestically. The relatively weak medicines regulatory systems present in some countries increases the risk that poor-quality TB medicine may be procured, distributed and used. The session will explore how global supply mechanisms, national TB programs, and medicines regulatory systems can work in a coordinated manner to ensure the continuous supply of quality-assured TB medicines in global and local markets and provides implementation examples from the Promoting the Quality of Medicines program.
Speakers: Dr. Archil Salakaia, United States Pharmacopeial Convention; Jennifer Derry, United States Pharmacopeial Convention; Dr. Paul Nkansah, United States Pharmacopeial Convention